Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement.

J, Herrmann; D, Lenihan; S, Armenian; A, Barac; A, Blaes; D, Cardinale; J, Carver; S, Dent; B, Ky; AR, Lyon; T, López-Fernández; MG, Fradley; S, Ganatra; G, Curigliano; JD, Mitchell; G, Minotti; NN, Lang; JE, Liu; TG, Neilan; A, Nohria; R, O'Quinn; I, Pusic; C, Porter; KL, Reynolds; KJ, Ruddy; P, Thavendiranathan; P, Valent

doi:10.1093/eurheartj/ehab674

Public

Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement.

Shared by NobleBlocks on Jan 1, 2022 • 12:00 AM UTC

Authors:

Herrmann J

Lenihan D

Armenian S

Abstract

The discipline of Cardio-Oncology has seen tremendous growth over the past decade. It is devoted to the cardiovascular (CV) care of the cancer patient, especially to the mitigation and management of CV complications or toxicities of cancer therapies, which can have profound implications on prognosis...

Subject

Hypertension

Cardiotoxicity

Myocarditis

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!